KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Shares Outstanding (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Shares Outstanding for 17 consecutive years, with $2.9 billion as the latest value for Q2 2025.

  • On a quarterly basis, Shares Outstanding changed 0.0% to $2.9 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $2.9 billion, a 0.0% change, with the full-year FY2024 number at $2.9 billion, changed 0.0% from a year prior.
  • Shares Outstanding was $2.9 billion for Q2 2025 at Bristol Myers Squibb, roughly flat from $2.9 billion in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $2.9 billion in Q4 2021 to a low of $692.0 million in Q1 2021.
  • A 5-year average of $2.6 billion and a median of $2.9 billion in 2021 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: tumbled 76.02% in 2021, then surged 316.98% in 2022.
  • Bristol Myers Squibb's Shares Outstanding stood at $2.9 billion in 2021, then changed by 0.0% to $2.9 billion in 2022, then changed by 0.0% to $2.9 billion in 2023, then changed by 0.0% to $2.9 billion in 2024, then changed by 0.0% to $2.9 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Shares Outstanding are $2.9 billion (Q2 2025), $2.9 billion (Q1 2025), and $2.9 billion (Q4 2024).